Skip to content

Pancreatic Surgery and Risk Factors

The Risk Factors and Prognosis of Hyperglycemia Secondary to Pancreatic Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06585046
Enrollment
382
Registered
2024-09-05
Start date
2017-01-01
Completion date
2024-08-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Pancreatic Surgey

Keywords

Pancreatic Surgey, Diabetes Mellitus, PCRD, Risk factor

Brief summary

The goal of this observational study is to learn about post-pancreatic surgery diabetes mellitus(PCRD).The main questions it aims to answer are: 1. What are the clinical characteristics of PCRD? 2. What are the related factors for PCRD? All patients with pancreatic surgery have been given standardized treatment fot the condition. The researchers will summarize the risk factors for PCRD from the PCRD group.

Detailed description

Sponsors retrospectively collected data from patients with pancreatic surgery in Changzheng centers between January 2017 and June 2024.

Interventions

PROCEDUREpancreatic surgery

patients who did pancreas-related surgery

Sponsors

Shanghai Changzheng Hospital
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1\. Age ≥18 years and \<80 years, male or female; 2. Patients who underwent pancreatic resection in pancreaticobiliary surgery since January 2017 3. Those who have previously completed a cohort study in pancreaticobiliary surgery and signed informed consent; 4. Those who have completed and banked serum specimens and pathology specimens in our hospital. \-

Exclusion criteria

1\. Age \<18 years or ≥80 years; 2. Those with preoperative fasting blood glucose ≥5.8 mmol/l or HbA1c ≥6.0% or a history of diabetes; 3. Those with missing relevant data. \-

Design outcomes

Primary

MeasureTime frameDescription
Incidence of glycaemic disorders(prevalence of diabetes) (postoperative fasting blood glucose/HbA1C)(within 5 years after surgery)The main objective of this study was the incidence of glucose metabolism disorders in patients treated with pancreatic surgery in our centre.

Secondary

MeasureTime frame
overall survivalwithin 5 years after surgery
Disease-Free Survivalwithin 5 years after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026